Page last updated: 2024-08-25

7-hydroxystaurosporine and Lymphoma, Primary Effusion

7-hydroxystaurosporine has been researched along with Lymphoma, Primary Effusion in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Arena, A; Benedetti, R; Cirone, M; Gaeta, A; Gilardini Montani, MS; Romeo, MA	1

Other Studies

1 other study(ies) available for 7-hydroxystaurosporine and Lymphoma, Primary Effusion

Article	Year
DNA damage triggers an interplay between wtp53 and c-Myc affecting lymphoma cell proliferation and Kaposi sarcoma herpesvirus replication. Biochimica et biophysica acta. Molecular cell research, 2022, Volume: 1869, Issue:1 Topics: Cell Line; Cell Proliferation; Cells, Cultured; Checkpoint Kinase 1; DNA Damage; Herpesvirus 8, Human; Humans; Leukocytes, Mononuclear; Lymphoma, Primary Effusion; Phthalazines; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-myc; Staurosporine; Tumor Suppressor Protein p53; Virus Replication	2022

Article

Year

DNA damage triggers an interplay between wtp53 and c-Myc affecting lymphoma cell proliferation and Kaposi sarcoma herpesvirus replication.

Biochimica et biophysica acta. Molecular cell research, 2022, Volume: 1869, Issue:1

Topics: Cell Line; Cell Proliferation; Cells, Cultured; Checkpoint Kinase 1; DNA Damage; Herpesvirus 8, Human; Humans; Leukocytes, Mononuclear; Lymphoma, Primary Effusion; Phthalazines; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-myc; Staurosporine; Tumor Suppressor Protein p53; Virus Replication

2022